Max Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050
Max Healthcare Institute Limited is a leading healthcare organization operating hospitals, home care, and pathology services. The company primarily focuses on providing healthcare in metro and Tier-1 cities. Abhay Soi has been promoted and led the company as chairman and managing director. The current company structure was formed after Radiant Life Care merged with the former Max Healthcare.
What is Max Healthcare Ltd?
Contents
- 1 What is Max Healthcare Ltd?
- 2 Max Healthcare share price Target Tomorrow
- 3 Max Healthcare share price Target 2025
- 4 Max Healthcare share price Target 2026
- 5 Max Healthcare share price Target 2030
- 6 Share price Target 2040
- 7 share price Target 2050
- 8 Should I buy Max Healthcare stock?
- 9 Max healthcare earning results
- 10 Key Metrics
- 11 Peers & Comparison
- 12 Is Max Healthcare stock good to buy? (Bull case & bear case)
- 13 Conclusion
- 14 FAQs
Max Healthcare Ltd is a leading healthcare company in India, established in 2000 and headquartered in New Delhi. It does business in the medical and healthcare services sector and runs home care and pathology services. The company specializes in treatments for cancer, heart diseases, diabetes, eye care, stomach and liver issues, minimally invasive surgeries, brain and nerve conditions, organ transplants, robotic surgeries, and joint replacements, among others. Max Healthcare manages multiple healthcare facilities in Uttar Pradesh, Delhi, Mumbai, Punjab, and Uttarakhand.
At the current time, the stock is trading around ₹1150. For some days the price going in a downward direction. The stock has made an M-shaped pattern and is predicted to fall more in the upcoming days. For the short term, you can short sell and for the buying, you should wait for now.
| Day | Minimum Price (Rs) | Maximum Price (Rs) |
| Tomorrow | -70 | +60 |
It is one of the largest healthcare companies in India, operating hospitals in major cities across the country. The company offers various healthcare services, including eye care, skin care, lung transplants, dental care, and more. This company has shown strong growth, especially during the pandemic, and continues to expand its business in new locations, indicating potential for further growth. In 2025, its stock price target would be ₹1800 as per our analysis.
By our analysis, its stock price would be between ₹800 to ₹1800 in 2025.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2025 | 800 | 1800 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 880 | 1360 |
| February | 933 | 1400 |
| March | 980 | 1420 |
| April | 1050 | 1400 |
| May | 1100 | 1430 |
| June | 1180 | 1450 |
| July | 1230 | 1470 |
| August | 1230 | 1488 |
| September | 1470 | 1500 |
| October | 1480 | 1621 |
| November | 1590 | 1779 |
| December | 1760 | 1800 |
The company is focusing on using new technology and providing great care, which is part of the trend in the healthcare industry. Experts think that if it keeps improving and making smart investments, its stock price could go up a lot. The company’s focus on being environmentally friendly and helping the community also makes investors more confident about its future. By 2026, its stock price target would be ₹2500 as per our prediction.
As per our analysis, its stock price would be between ₹1760 to ₹2500 in 2026.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2026 | 1760 | 2500 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 1760 | 1820 |
| February | 1788 | 1838 |
| March | 1810 | 1880 |
| April | 1850 | 1930 |
| May | 1880 | 1970 |
| June | 1955 | 2035 |
| July | 1980 | 2070 |
| August | 2044 | 2170 |
| September | 2140 | 2235 |
| October | 2210 | 2360 |
| November | 2280 | 2430 |
| December | 2408 | 2500 |
The company is working on growing its business quickly by both improving its current operations and buying other companies. Recently, the company has been acquiring businesses in its sector, which is helping it grow faster. It is also teaming up with other institutions and businesses to boost its growth. In the future, It plans to buy and partner with more healthcare companies, which will help it expand even more. By 2030, its stock price target would be ₹4310 as per our experts, prediction.
In 2030, its stock price would be between ₹3700 to ₹4310 in 2030, as per our expert’s analysis.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2030 | 3700 | 4310 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 3700 | 3788 |
| February | 3743 | 3860 |
| March | 3800 | 3910 |
| April | 3870 | 3960 |
| May | 3910 | 3988 |
| June | 3950 | 4020 |
| July | 3987 | 4054 |
| August | 4000 | 4090 |
| September | 4070 | 4150 |
| October | 4120 | 4180 |
| November | 4150 | 4260 |
| December | 4240 | 4310 |
India’s medical sector has a lot of growth opportunities, especially in Tier 2 and Tier 3 cities. During the pandemic, it became clear that these cities lacked proper medical infrastructure, such as equipment and beds. This creates a big chance for companies in the healthcare sector to grow. This company is planning to expand its business in these cities by working with local doctors. As the company grows in smaller and larger cities across India, its share price is also expected to rise significantly. So by 2040, its stock price target would be ₹8321 as per our prediction.
By our analysis, its stock price would be between ₹7125 to ₹8321 in 2040.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2040 | 7125 | 8321 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 7125 | 7260 |
| February | 7190 | 7340 |
| March | 7267 | 7465 |
| April | 7370 | 7560 |
| May | 7460 | 7680 |
| June | 7569 | 7760 |
| July | 7680 | 7890 |
| August | 7756 | 7955 |
| September | 7869 | 8035 |
| October | 7960 | 8136 |
| November | 8056 | 8271 |
| December | 8233 | 8321 |
India’s healthcare industry is growing quickly compared to other countries, but investment in this sector is still much lower than in developed nations. As government and private sector investments increase in the future, companies in this industry are expected to grow significantly. Also, as people’s incomes rise, they are more likely to spend on quality healthcare services. This will lead to more people seeking better treatment, benefiting this sector in the coming years. By 2050, its stock price target would be ₹15800 as per our expert’s analysis.
Its stock price would be between ₹14200 to ₹15800 in 2050, as per our expert’s analysis.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2050 | 14200 | 15800 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 14200 | 14368 |
| February | 14330 | 14470 |
| March | 14400 | 14590 |
| April | 14510 | 14650 |
| May | 14589 | 14780 |
| June | 14620 | 14880 |
| July | 14780 | 14970 |
| August | 14890 | 14180 |
| September | 14120 | 14380 |
| October | 14270 | 14560 |
| November | 14470 | 14720 |
| December | 14680 | 15800 |
Should I buy Max Healthcare stock?
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2025 | 800 | 1800 |
| 2026 | 1760 | 2500 |
| 2030 | 3700 | 4310 |
| 2040 | 7125 | 8321 |
| 2050 | 14200 | 15800 |
This company shows strong long-term growth potential due to its leading position in the healthcare sector, focus on advanced technology, and expansion plans. However, the stock is currently in a downward trend, indicating short-term challenges. While it’s a good option to invest for the long term, but at the current time the stock is currently falling, so it’s better to wait for a lower price before buying.
Max healthcare earning results
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
| Sales + | 1,608 | 1,729 | 1,691 | 1,884 | 2,508 | 3,937 | 4,563 | 5,406 | 6,008 |
| Expenses + | 1,467 | 1,616 | 1,535 | 1,595 | 2,101 | 2,986 | 3,322 | 3,914 | 4,403 |
| Operating Profit | 141 | 113 | 156 | 289 | 407 | 951 | 1,241 | 1,492 | 1,605 |
| OPM % | 9% | 7% | 9% | 15% | 16% | 24% | 27% | 28% | 27% |
| Other Income + | 59 | 65 | 56 | 72 | -122 | 110 | 139 | 178 | 167 |
| Interest | 100 | 99 | 101 | 153 | 179 | 101 | 84 | 60 | 89 |
| Depreciation | 96 | 94 | 103 | 120 | 174 | 221 | 232 | 245 | 292 |
| Profit before tax | 5 | -15 | 8 | 89 | -69 | 739 | 1,064 | 1,365 | 1,390 |
| Tax % | -236% | 65% | 102% | -7% | 67% | 18% | -4% | 23% | |
| Net Profit + | 16 | -25 | -0 | 95 | -138 | 605 | 1,104 | 1,058 | 1,059 |
| EPS in Rs | 0.29 | -0.47 | -0.06 | 1.77 | -1.42 | 6.24 | 11.37 | 10.88 | 10.90 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 14% |
Key Metrics
| TTM PE Ratio | PB Ratio | Dividend Yield | Sector PE | Sector PB | Sector Div Yld |
| 105.56 | 13.29 | 0.13% | 50.66 | 6.57 | 0.53% |
Peers & Comparison
| Stock | PE Ratio | PB Ratio | Dividend Yield |
| Max Healthcare Institute Ltd | 105.69 | 13.29 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 112.59 | 13.82 | 0.23% |
| Fortis Healthcare Ltd | 86.63 | 6.06 | 0.15% |
| Global Health Ltd | 79.82 | 10.11 | — |
Is Max Healthcare stock good to buy? (Bull case & bear case)
Bull Case:
- Strong long-term growth potential with expansion plans.
- Focus on technology and improving healthcare services.
- Rising demand in India’s growing healthcare sector.
- Delivered impressive profit growth of 780% CAGR over the last 5 years.
- Experienced management with a solid growth strategy.
Bear Case:
- Stock is trading at 12.7 times its book value, which may indicate overvaluation.
- Low return on equity of 13.4% over the last 3 years.
- Promoter holding has decreased by 37.2% over the last 3 years.
- Current downward trend in stock price.
- Manageable but present debt could be a risk.
- Intense competition in the healthcare market.
Conclusion
It is a leading healthcare company with strong long-term growth potential due to its advanced services. However, the stock is currently in a downward trend, making it better to wait for a price correction before investing. In this article, we have provided you with the main details about this company, if you planning to invest or are confused you should read the whole article.
FAQs
Similar Stocks
